Welcome to visit Acta Anatomica Sinica! Today is
Chinese
Induction effect of hepatocyte growth factor and insulin-like growth factor on cardiac stem cells
ZHU Bei-bei CAI Xin-hua SUN Yin-ping*
Acta Anatomica Sinica ›› 2014, Vol. 45 ›› Issue (5) : 663-669.
Induction effect of hepatocyte growth factor and insulin-like growth factor on cardiac stem cells
Objective To investigate whether hepatocyte growth factor (HGF) and insulin-like growth factor (IGF1) induce cardiac stem cells (CSCs) to proliferate and directly differentiate into cardiomyocytesin vitro. Methods The myocardial tissues were dissected for primary culture of CSCs with the method of explants. The expressions of c-kit and CD34 were examined with immunofluorescence. Primary cells were purified with c-kit by flow cytometry. CFDA SE fluorescent probe was used to detect the proliferation of c-kit+CSCs. C-kit+CSCs were divided into two groups, and cardiac stem cells group and co-cultured with cardiomyocytes group, both group were cultured with HGF and IGF1. An inverted microscope was used to observe changes in cell number and morphology in different periods. Living cells workstation was used to observe CFDA SE fluorescence intensity, to acquire images and do statistical analysis. Immunofluorescence technique was used to detect the expression of Nkx2.5 and cardiac troponin T. Results In cardiac stem cells group，CSCs had no obvious changes in cell number. In co-cultured with cardiomyocytes group, CSCs proliferated and had changes in morphology. Nkx2.5 and cTnT were positively expressed. Several CSCs differentiated into beating cardiomyocytes. Conclusion In co-cultured with cardiomyocytes condition, HGF and IGF1 may promote CSCs to proliferate and differentiate into beating cardiomyocytes.
Cardiac stem cell / Proliferation / Cardiac differentiation / Hepatocyte growth factor / Insulin-like growth factor / Immunofluorescence / Rat
［1］Ding BL, Li T, Wu ZhG. Research advances in growth factors to mobilize resident cardiac stem cells to repair myocardial injury［J］.Guangdong Medical Journal, 2012, 33(6): 864-867. (in Chinese)
丁碧蓝,李涛,吴柱国. 生长因子动员原位心肌干细胞修复心肌损伤的研究进展［J］. 广东医学， 2012， 33(6): 864-867.
［2］Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart［J］. Circ Res, 2004, 95(9): 911-921.
［3］Fuentes T, Kearns-Jonker M. Endogenous cardiac stem cells for the treatment of heart failure［J］. Stem Cells Cloning. 2013, 6: 1-12.
［4］Linke A, Muller P,Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function［J］. Proc Natl Acad Sci USA, 2005, 102(25): 8966-8971.
［5］Chen W, Zhang L, Kong XZ, et al. Differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes induced by exogenous NKx2.5 gene［J］. Acta Anatomica Sinica, 2012, 43(4):484-489. (in Chinese)
陈炜,张雷,孔祥增,等.外源表达Nkx2.5诱导骨髓间充质干细胞向心肌分化［J］.解剖学报, 2012, 43(4):484-489.
［6］Liu XCh, Zhu Y. Proliferative effect of insulin-like growth factor-1 on muscle-derived stem cells ［J］. Acta Anatomica Sinica, 2008, 39(1):79-82. (in Chinese)
刘欣春,朱悦.胰岛素样生长因子-1对骨骼肌源性干细胞的促增殖效应［J］.解剖学报, 2008,39(1):79-82.
［7］Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart［J］. J Am Coll Cardiol, 2011, 58(9): 977-986.
［8］Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes［J］. Circulation, 2003, 107(7): 1024-1032.
［9］Christalla P, Hudson JE, Zimmermann WH. The cardiogenic niche as a fundamental building block of engineered myocardium［J］. Cells Tissues Organs, 2012, 195(1-2): 82-93.
［10］Feng Y, Yu XY, Wang Y. Recent concepts for the roles of progenitor/stem cell niche in heart repair［J］. Am J Cardiovasc Dis, 2012, 2(1): 75-83.
［11］Krankel N, Spinetti G, Amadesi S, et al. Targeting stem cell niches and trafficking for cardiovascular therapy［J］. Pharmacol Ther, 2011, 129(1): 62-81.
［12］Beitnes JO, Lunde K, Brinchmann JE, et al. Stem cells for cardiac repair in acute myocardial infarction［J］. Expert Rev Cardiovasc Ther, 2011, 9(8): 1015-1125.
［13］Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial［J］. Lancet, 2011, 378(9806): 1847-1857.
［14］HKh H, Mustafa A, Feng Y, et al. Genetic modification of stem cells for improved therapy of the infarcted myocardium［J］. Mol Pharm, 2011, 8(5): 1446-1457.
［15］Karantalis V, Balkan W, Schulman IH, et al. Cell-based therapy for prevention and reversal of myocardial remodeling［J］. Am J Physiol Heart Circ Physiol, 2012, 303(3): H256-270.
［16］Choi JS, Harley BA. The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells［J］. Biomaterials, 2012, 33(18): 4460-4468.
［17］Ou NW, Lu DF, Yang ZhJ, et al. Study on differentiation of murine cardiac stem cells cocultured with cardiomyocytes［J］. Chinese Journal of Thrombosis and Hemostasis, 2010, 2 (1):5-9. (in Chinese)
欧念文,陆东风,杨镇军,等.新生小鼠心肌干细胞与心肌细胞共培养诱导分化试验［J］.血栓与止血学, 2010, 2 (1):5-9.
/
| 〈 |
|
〉 |
